Dr Reddy`s launches skin moisturising cream in India

Drug major Dr Reddy`s Laboratories today launched Rebask cream used for moisturising skin in the Indian market.

Dr Reddy`s launches generic cholesterol-lowering drug in US

Dr Reddy`s Laboratories today launched generic version of Pfizer`s Caduet tablets, a cholesterol-lowering drug, in the American market after getting the approval from the US health regulator.

Dr Reddy`s launches antibiotic drug in US market

Dr Reddy`s Laboratories Ltd has launched Moxifloxacin Hydrochloride tablets in the US market for the treatment of a wide range of diseases, including pneumonia, bronchitis and skin infections.

Dr Reddy`s launches Alzheimer`s disease drug in US market

Drug firm Dr Reddy`s Laboratories today said it has launched generic Donepezil Hydrochloride tablets, used to treat Alzheimer`s disease, in the US market.

Dr Reddy`s launches generic Zoledronic Acid injection in US

Drug firm Dr Reddy`s Laboratories today said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget`s disease of bone in the US market following approval from the US health regulator.

Dr Reddy`s gets USFDA nod for generic Zenatane capsules

Drug firm Dr Reddy`s Laboratories today said it has launched its generic Zenatane capsules in the US market following approval from the US health regulator.

Dr Reddy`s launches tablets to treat hair loss

Drug firm Dr Reddy`s Laboratories today said it has launched it`s generic Finasteride tablets used for treating male pattern hair loss in the American market.

Dr Reddy`s launches Amoxicillin tablets in US market

Dr Reddy`s Laboratories today announced the launch of antibiotic Amoxicillin tablets, capsules and oral suspension.

Dr Reddy`s launches high BP tablets in US

Drug firm Dr Reddy`s Laboratories today said it has launched Metoprolol Succinate tablets used for treating high blood pressure in the American market.

Dr Reddy`s launches generic Parkinson`s drug in US

Dr Reddy`s Laboratories today said it has launched its generic Ropinirole Hydrochloride XR tablets used for treating Parkinson`s disease in the American market after receiving approval from the US health regulator.

Dr Reddy`s, Merck Serono sign pact for biosimilars

Dr Reddy`s Laboratories (DRL) today said it has entered into a partnership with Merck Serono to co-develop, manufacture and market a portfolio of biosimilar compounds in oncology.

Dr Reddy`s, Sun Pharma get USFDA nod for heart disease drug

Drug firms Dr Reddy`s Laboratories, Sun Pharma and Aurobindo Pharma today said they have received US health regulator`s approval to sell generic Plavix, used in treating heart diseases, in the American market.

7 Indian cos in Asia`s top 20 life science firms

Seven Indian companies are among
Asia`s top 20 publicly listed life science companies, says a
study.

Dr Reddy`s `Benazepril` capsules now in US market

Dr Reddy`s Laboratories on Monday announced that it has launched Amlodipine Benazepril capsules, a bio-equivalent generic version of Lotrel Capsules, in the US market.

Dr Reddy`s `Benazepril` capsules now in US market

Dr Reddy`s Laboratories on Monday announced that it has launched Amlodipine Benazepril capsules, a bio-equivalent generic version of Lotrel Capsules, in the US market.

Dr Reddy`s Q2 net up 3 fold at Rs 240 cr

Pharma firm Dr Reddy`s on Friday reported a near three-fold jump in its consolidated net profit at Rs 239.85 crore for the second quarter ended September 30, 2009.